14 July 2021 - News Deck

State-of-art High Precision & Safe Linear Accelerator to Help Cancer Radiotherapy Tumour Patients

14 July 202114 July 2021 Vijay Raman

Chennai, Tamil Nadu, India Dr. Kamakshi Memorial Hospital Pallikaranai announced the arrival of state-of-art Cancer Radiotherapy Equipment which promises to be a boon to cancer tumour patients. Dr. Kamakshi Memorial Hospital Oncology Team with Dr. T.G. Govindarajan, Founder & Chairman According to the Founder & Chairman Dr. T.G. Govindarajan “The Elekta Infinity Linear Accelerator is a high precision device that has revolutionised Radiotherapy in Cancer Patients. Radiation plays a very vital role in treating Breast Cancer, Uterine Cervix Cancer, Brain Tumours, Prostate Cancer, Tumours in the Liver & Lungs and even Paediatric Cancer.…

UK – National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on ‘Trublood®- Prostate’ for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a ‘Game Changer’

14 July 202114 July 2021 Vijay Raman

MUMBAI, India and LONDON, July 13, 2021 /PRNewswire/ — Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head Quarters at Nasik, India, announced the publication of the internationally recognized MedTech Innovation Briefing (MIB) from the United Kingdom’s National Institute for Health and Care Excellence (NICE) on its CE marked ‘Trublood®– Prostate’ test to be used for precision triaging of patients to avoid unnecessary invasive biopsies. MIBs are published as “NICE advice” series to U.K. National Health Service (NHS) hospitals and clinical commissioning groups…

ZEISS Introduces the Fully Integrated, Data-Driven Medical Ecosystem

14 July 202114 July 2021 Vijay Raman

The ZEISS Medical Ecosystem enables multiple layers of added value by connecting devices, data and applications to optimize clinical management of patients. JENA, Germany and DUBLIN, Calif., July 13, 2021 /PRNewswire/ — ZEISS today announced its new ZEISS Medical Ecosystem, a fully integrated environment where a combination of devices, data management, applications and services drive continuous improvement of patient outcomes. This ecosystem distinctively combines unsurpassed ocular expertise with leading-edge digital technology enabling evidence-based decisions that assure more efficient delivery of the highest quality of care in a single and secure…